共 50 条
Treatment and outcome of biopsy-proven fulminant myocarditis in adults
被引:11
|作者:
Chau, EMC
[1
]
Chow, WH
Chlu, CSW
Wang, E
机构:
[1] Grantham Hosp, Dept Cardiol, Aberdeen, Hong Kong, Peoples R China
[2] Grantham Hosp, Dept Cardiothorac Surg, Hong Kong, Hong Kong, Peoples R China
[3] Grantham Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
关键词:
fulminant myocarditis;
endomyocardial biopsy;
immunosuppression;
mechanical circulatory support;
D O I:
10.1016/j.ijcard.2005.07.082
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Fulminant myocarditis may be rapidly fatal with severe haemodynamic compromise in previously healthy patients. We reviewed our experience with eight cases of biopsy-proven fulminant myocarditis (seven cases with lymphocytic myocarditis and one with eosinophilic myocarditis). Immunosuppression was given in seven out of eight cases. Mechanical circulatory support was required in 50% of the patients. Time from onset of illness to recovery of ventricular function varied from 12 to 17 days. All except one patient were alive at a mean follow-up of 4.4 years after the acute illness. Patients with acute fulminant myocarditis should be treated aggressively with immunosuppression and, if necessary, mechanical circulatory support during the first 2 to 3 weeks of the illness because of the reversible nature of this illness and good long-term prognosis. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:405 / 406
页数:2
相关论文